Modeyso is the first and only approved treatment for recurrent H3 K27M-mutant diffuse midline glioma in patients aged one ...

The company is streamlining its global workforce as part of a multi-year cost-cutting strategy, while raising its 2025 ...

XtalPi and DoveTree collaborate on a groundbreaking $6 billion drug discovery partnership, merging AI technology with ...

Chai Discovery secures $70 million to revolutionize AI-driven drug discovery, enhancing antibody design and accelerating breakthroughs in medicine.

With AI expected to play a significant role in drug approvals, how can companies build data sets that are ready for AI?